Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial

Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 NYX-2925 trial for neuropathic pain associated with diabetic peripheral neuropathy, including study methods, participant criteria, and outcome measures. It also includes study locations, record dates, and linked study documents.
    Difference
    62%
    Check dated 2026-11-07T13:50:20.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer now lists revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:39.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces updates to NIH websites and describes the transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T14:03:23.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:07:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error, while its footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:06:54.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error page, replacing the study details with a standard error screen and site footer.
    Difference
    18%
    Check dated 2026-09-19T18:02:42.000Z thumbnail image

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.